Early rheumatoid arthritis treated with tocilizumab, methotrexate, or their combination (U-Act-Early): a multicentre, randomised, double-blind, double-dummy, strategy trial

Author(s):
Bijlsma, J.W.J.; Welsing, P.M.J.; Woodworth, T.G.; Middelink, L.M.; Petho-Schramm, A.; Bernasconi, C.; Borm, M.E.A.; Wortel, C.H.; Borg, E.J. ter; Jahangier, Z.N.; Laan, W.H. van der; Bruyn, G.A.W.; Baudoin, P.; Wijngaarden, S.; Vos, P.A.J.M.; Bos, R.; Starmans, M.J.F.; Griep, E.N.; Griep-Wentink, J.R.M.; Allaart, C.F.; Heurkens, A.H.M.; Teitsma, X.M.; Tekstra, J.; Marijnissen, A.C.A.; Lafeber, F.P.J.; Jacobs, J.W.G.
Published
2016
Publication type
Article / Letter to editor
Date issued
2016-07-23
Language
English
Is part of
Lancet (2016), Vol. 388, no. 10042, p. 343-355
hdl
1887/113327